LUCISANO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 369
EU - Europa 81
AS - Asia 53
AF - Africa 1
Totale 504
Nazione #
US - Stati Uniti d'America 361
SE - Svezia 43
SG - Singapore 30
CN - Cina 22
IT - Italia 9
CA - Canada 8
BE - Belgio 7
DE - Germania 6
GB - Regno Unito 6
FI - Finlandia 4
CZ - Repubblica Ceca 2
EG - Egitto 1
FR - Francia 1
JP - Giappone 1
LT - Lituania 1
ME - Montenegro 1
RU - Federazione Russa 1
Totale 504
Città #
Chandler 81
Fairfield 39
Ashburn 38
Nyköping 35
Woodbridge 28
Cambridge 18
Singapore 17
Seattle 16
Houston 15
Wilmington 14
Ann Arbor 12
Lawrence 8
Brussels 7
Roxbury 7
Beijing 6
Inglewood 6
Toronto 6
Bisceglie 4
Munich 4
Des Moines 3
Helsinki 3
San Diego 3
Bari 2
Brooklyn 2
Dearborn 2
Hangzhou 2
Princeton 2
Washington 2
Boardman 1
Brno 1
Clifton 1
Edinburgh 1
Frankfurt am Main 1
Grottaglie 1
Guangzhou 1
Hefei 1
Jinan 1
London 1
Los Angeles 1
Montreal 1
Nanchang 1
Nanjing 1
Ottawa 1
Paris 1
Podgorica 1
Prague 1
Santa Clara 1
Shanghai 1
Shenyang 1
Tokyo 1
Weifang 1
Yinchuan 1
Yiwu 1
Zhengzhou 1
Totale 408
Nome #
null 63
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review 61
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 51
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies 50
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors 45
null 39
Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial 39
null 32
Risk of Getting COVID-19 in People With Multiple Sclerosis 29
Characterization of the rs2802292 SNP identifies FOXO3A as a modifier locus predicting cancer risk in patients with PJS and PHTS hamartomatous polyposis syndromes 27
The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study 24
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis 22
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register 12
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study 10
Big Multiple Sclerosis Data network: an international registry research network 10
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry 7
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 6
Multiple Sclerosis Progression and Relapse Activity in Children 5
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis 1
Totale 533
Categoria #
all - tutte 3.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 8 7 10 9 10 4 4 3
2020/202174 1 3 1 7 10 10 0 9 5 7 4 17
2021/202278 2 8 0 3 4 9 4 5 5 9 10 19
2022/2023162 20 25 12 14 17 20 1 24 20 1 7 1
2023/202466 10 8 4 6 7 11 0 6 1 4 0 9
2024/202560 21 8 8 16 7 0 0 0 0 0 0 0
Totale 533